Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ningbo Second Hormone Factory (NSHF) is a leading Chinese pharmaceutical company established in 1988 that specializes in the research, development, and manufacture of veterinary reproductive hormones and active pharmaceutical ingredients (APIs). The company provides a comprehensive portfolio of hormones used in swine, cattle, sheep, fish, and pets, leveraging nearly four decades of experience in human pharmaceuticals to apply advanced drug manufacturing technologies to veterinary medicine. NSHF's product line includes key hormones such as oxytocin, progesterone, altrenogest, buserelin, carbetocin, and cloprostenol sodium. It operates state-of-the-art, fully automated manufacturing lines with GMP certification, producing tens of millions of freeze-dried powder and water injection units annually.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NSHF.